Clinical Trial Update: Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating encochleated oral amphotericin for cryptococcal meningitis is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptococcal Meningitis

Drugs mentioned

• Encochleated oral amphotericin (amphotericin)

Snippet

Sponsor: Matinas BioPharma Nanotechnologies, Inc. | Conditions: Cryptococcal Meningitis | Phase 3 | Status: UNKNOWN